Findings from National Institute of Allergy and Infectious Diseases (NIAID) in Influenza A Virus Reported (Co-immunization With Hemagglutinin Stem Immunogens Elicits Cross-group Neutralizing Antibodies and Broad Protection Against Influenza a ...).

Předmět:	INFLUENZA A virus INFLUENZA viruses COMMUNICABLE diseases HEMAGGLUTININ IMMUNOGLOBULINS VIRAL shedding HUMORAL immunity
Zdroj:	Vaccine Weekly; 2/12/2023, p268-268, 1p
Abstrakt:	Keywords: Bethesda; State:Maryland; United States; North and Central America; Antibodies; Biological Products; Blood Proteins; Health and Medicine; Immunization; Immunoglobulins; Immunology; Immunoproteins; Influenza A Virus; Neutralizing Antibodies; Orthomyxoviridae; Proteins; RNA Viruses; Risk and Prevention; Serum Globulins; Vaccines; Viral; Virology EN Bethesda State:Maryland United States North and Central America Antibodies Biological Products Blood Proteins Health and Medicine Immunization Immunoglobulins Immunology Immunoproteins Influenza A Virus Neutralizing Antibodies Orthomyxoviridae Proteins RNA Viruses Risk and Prevention Serum Globulins Vaccines Viral Virology 2023 FEB 8 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on RNA Viruses - Influenza A Virus have been published. According to the news editors, the research concluded: "Vaccine elicitation of stem -directed cross-group-protective immunity represents a step toward the development of broadly protective influenza vaccines.". [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu